lamotrigine and blood dyscrasias
- various blood dyscrasias have been reported associated with the use of
- assessment of individual reports indicates that lamotrigine is likely to
be the causative factor in the reported cases of blood dyscrasias associated
with use of lamotrigine
- routine FBC monitoring is not, at present, recommended in patients treated with lamotrigine
Check the summary of product characteristics before prescribing this drug.
Last reviewed 01/2018